Goldman Sachs’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$388K Sell
1,180,544
-611,570
-34% -$961K ﹤0.01% 5755
2025
Q4
$5.56M Buy
1,792,114
+1,492,532
+498% +$4.26M ﹤0.01% 3658
2025
Q3
$788K Buy
299,582
+138,887
+86% +$306K ﹤0.01% 5198
2025
Q2
$198K Sell
160,695
-778,908
-83% -$850K ﹤0.01% 5668
2025
Q1
$1.03M Buy
939,603
+825,047
+720% +$954K ﹤0.01% 4667
2024
Q4
$104K Sell
114,556
-616,198
-84% -$528K ﹤0.01% 5759
2024
Q3
$721K Sell
730,754
-1,386,960
-65% -$1.33M ﹤0.01% 4851
2024
Q2
$1.91M Sell
2,117,714
-576,251
-21% -$431K ﹤0.01% 3958
2024
Q1
$3.18M Sell
2,693,965
-32,286
-1% -$35.5K ﹤0.01% 3499
2023
Q4
$2.49M Buy
2,726,251
+1,061,749
+64% +$784K ﹤0.01% 3756
2023
Q3
$1.39M Buy
1,664,502
+1,260,635
+312% +$1.45M ﹤0.01% 4030
2023
Q2
$485K Sell
403,867
-927,955
-70% -$1.16M ﹤0.01% 4768
2023
Q1
$1.68M Sell
1,331,822
-436,995
-25% -$836K ﹤0.01% 3998
2022
Q4
$3.84M Buy
1,768,817
+717,305
+68% +$5.91M ﹤0.01% 3406
2022
Q3
$12.6M Buy
1,051,512
+410,923
+64% +$5.1M ﹤0.01% 2298
2022
Q2
$5.36M Buy
640,589
+184,697
+41% +$1.43M ﹤0.01% 3067
2022
Q1
$3.96M Buy
455,892
+211,804
+87% +$2.04M ﹤0.01% 3568
2021
Q4
$2.76M Sell
244,088
-327,829
-57% -$3.89M ﹤0.01% 3968
2021
Q3
$7.19M Buy
571,917
+60,342
+12% +$555K ﹤0.01% 3027
2021
Q2
$4.15M Sell
511,575
-465,522
-48% -$4.04M ﹤0.01% 3506
2021
Q1
$9.04M Buy
977,097
+124,743
+15% +$1.26M ﹤0.01% 2657
2020
Q4
$8.24M Buy
852,354
+41,190
+5% +$406K ﹤0.01% 2620
2020
Q3
$10.1M Buy
811,164
+637,832
+368% +$8.46M ﹤0.01% 2320
2020
Q2
$2.25M Buy
173,332
+99,005
+133% +$1.25M ﹤0.01% 3373
2020
Q1
$754K Sell
74,327
-24,234
-25% -$316K ﹤0.01% 3945
2019
Q4
$1.54M Buy
+98,561
New +$1.99M ﹤0.01% 3835
2019
Q2
Sell
-99,531
Closed -$2.16M 5213
2019
Q1
$2.16M Buy
+99,531
New +$2.08M ﹤0.01% 3598

Other funds holding GOSS